Skip to Main Content
upf.edu
  • Studies
  • Research
  • Knowledge transfer
  • Services
  • University
Information addressed to ...
  • Prospective students
  • Alumni
  • International students
  • Companies and organizations
  • Media
Contact Online office
En
CG
Campus Global
RDI Portfolio
  • Areas of knowledge
    • Health and Life Sciences
    • Information & Communication Technologies
    • Social Sciences and Humanities
  • Type of content
    • Technologies / Software
    • Patents
    • Research groups
    • Spin-off
  • About
More ...
RDI Portfolio
  • Areas of knowledge
    • Health and Life Sciences
    • Information & Communication Technologies
    • Social Sciences and Humanities
  • Type of content
    • Technologies / Software
    • Patents
    • Research groups
    • Spin-off
  • About
upf.edu
  • Studies
  • Research
  • Services
  • University
Information addressed to...
  • Prospective students
  • Alumni
  • International students
  • Companies and organizations
  • Media
Contact
Menú
En
CG
Campus Global
  • inici /
  • Content
  • /
  • Research Group - Integrative Biomedical Materials and Nanomedicine Lab

Research Group - Integrative Biomedical Materials and Nanomedicine Lab

The Research Group on Integrative Biomedical Materials and Nanomedicine Lab is led by Dr. Pilar Rivera. The group converts basic research findings on nanobiotechnology into new approaches addressing biomedical challenges. They fabricate multifunctional biomaterials by integrating selected building-blocks into one single system depending on the application's requirements and considering the biophysicochemical properties of the nanomaterial. They group targets independently two areas: diagnostics and therapeutics of diseases but also simultaneously by creating a theranostic tool towards a more personalized medicinal approach of diseases. They focus on understanding and engineering the nanomaterial-biological system interface. They use state of the art material and biological/molecular characterization methods to find predictive patterns of cellular outcomes after exposure to nanomaterials for translational medicine.

Research Group Website

Related Assets

  • Patent - NanoTARG: Increasing survival rate of pancreatic cancer patients with targeted nanomedicines
  • Patent - NanoLUXE: unique optical labelling of exclusive goods for product authentication
Connect
  • Innovation Unit - UPF Business Shuttle
  • Contact
  • Our team
Follow us
Tech transfer office
  • The Innovation Unit - UPF Business Shuttle manages the transfer of the research results and capabilities shown in this website.

© Universitat Pompeu Fabra
Barcelona
T.(+34) 93 542 20 00

  • Legal notice
  • Accessibility
  • Technical note

We use cookies to deliver personalized content, analyze trends, administer the site, track user movements on the site, and collect demographic information about our user base as a whole. Accept all cookies for the best possible experience on our website or manage your preferences. Legal notice